Gilead Sciences Inc (GILD)
90.19
+0.43
(+0.48%)
USD |
NASDAQ |
Nov 22, 16:00
90.16
-0.03
(-0.03%)
After-Hours: 20:00
Gilead Sciences Cash from Financing (Quarterly): -1.379B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.379B |
| June 30, 2024 | -2.953B |
| March 31, 2024 | -1.361B |
| December 31, 2023 | -1.099B |
| September 30, 2023 | -1.519B |
| June 30, 2023 | -1.101B |
| March 31, 2023 | -1.406B |
| December 31, 2022 | -1.554B |
| September 30, 2022 | -2.118B |
| June 30, 2022 | -1.003B |
| March 31, 2022 | -1.794B |
| December 31, 2021 | -1.942B |
| September 30, 2021 | -3.527B |
| June 30, 2021 | -931.00M |
| March 31, 2021 | -2.477B |
| December 31, 2020 | 131.00M |
| September 30, 2020 | 4.124B |
| June 30, 2020 | -874.00M |
| March 31, 2020 | -2.611B |
| December 31, 2019 | -896.00M |
| September 30, 2019 | -2.515B |
| June 30, 2019 | -1.857B |
| March 31, 2019 | -2.366B |
| December 31, 2018 | -1.67B |
| September 30, 2018 | -2.901B |
| Date | Value |
|---|---|
| June 30, 2018 | -1.152B |
| March 31, 2018 | -6.595B |
| December 31, 2017 | 3.347B |
| September 30, 2017 | 2.17B |
| June 30, 2017 | -880.00M |
| March 31, 2017 | -1.244B |
| December 31, 2016 | -2.348B |
| September 30, 2016 | 2.797B |
| June 30, 2016 | -1.561B |
| March 31, 2016 | -8.613B |
| December 31, 2015 | -4.465B |
| September 30, 2015 | 6.644B |
| June 30, 2015 | -5.341B |
| March 31, 2015 | -2.722B |
| December 31, 2014 | 1.234B |
| September 30, 2014 | -5.772B |
| June 30, 2014 | -1.371B |
| March 31, 2014 | 2.884B |
| December 31, 2013 | -845.12M |
| September 30, 2013 | -942.23M |
| June 30, 2013 | -557.65M |
| March 31, 2013 | -199.00M |
| December 31, 2012 | -510.20M |
| September 30, 2012 | -307.51M |
| June 30, 2012 | -474.88M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.527B
Minimum
Sep 2021
4.124B
Maximum
Sep 2020
-1.314B
Average
-1.392B
Median
Cash from Financing (Quarterly) Benchmarks
| Eli Lilly and Co | 211.30M |
| Merck & Co Inc | -2.425B |
| Pfizer Inc | -4.636B |
| Amgen Inc | -3.651B |
| Vertex Pharmaceuticals Inc | -387.50M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.309B |
| Cash from Investing (Quarterly) | -710.00M |
| Free Cash Flow | 9.431B |
| Free Cash Flow Per Share (Quarterly) | 3.324 |
| Free Cash Flow to Equity (Quarterly) | 4.269B |
| Free Cash Flow to Firm (Quarterly) | 4.412B |
| Free Cash Flow Yield | 8.35% |